Citation Tools

Original research
Eligibility for faricimab in a real-world neovascular age-related macular degeneration population: a cross-sectional study

Download to a citation manager

Cite this article as:
Jern I, Forsell S, Norberg H
Eligibility for faricimab in a real-world neovascular age-related macular degeneration population: a cross-sectional study